Previous large studies have shown varying results for whether a complex karyotype may additionally provide prognostic information on TP53 mutant MDS following an allograft,12, 13 in part dependent on the study‐specific technologies used to detect chromosomal abnormalities. The gene discussed is TP53; the disease is myelodysplastic syndrome.